Integrated Filing — IndAS



General information about company
Scrip Code 506852
NSE Symbol PRIMO
MSEI Symbol NOTLISTED
ISIN INE607A01022
Name of company PRIMO CHEMICALS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 30-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 19-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment CHEMICALS
Start date and time of board meeting 30-May-2025   12:30:00
End date and time of board meeting 30-May-2025   15:45:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-05-30
Indicate Company website link for updated RPT policy of the Company https://primochemicals.in/investor/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not applicable as there is no default on loans and debt securities outstanding as on 31st March, 2025.



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 1554223000 5555581000
Other income 44147000 208887000
Total income 1598370000 5764468000
2 Expenses
(a) Cost of materials consumed 862010000 3373876000
(b) Purchases of stock-in-trade 59771000 214389000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -20465000 -34591000
(d) Employee benefit expense 128661000 502917000
(e) Finance costs 57761000 230080000
(f) Depreciation, depletion and amortisation expense 125185000 511057000
(f) Other Expenses
1 Other Expenses 284574000 815587000
Total other expenses 284574000 815587000
Total expenses 1497497000 5613315000
3 Total profit before exceptional items and tax 100873000 151153000
4 Exceptional items 0 0
5 Total profit before tax 100873000 151153000
6 Tax expense
7 Current tax 18062000 27969000
8 Deferred tax 94006000 99663000
9 Total tax expenses 112068000 127632000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations -11195000 23521000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period -11195000 23521000
17 Other comprehensive income net of taxes 695000 2589000
18 Total Comprehensive Income for the period -10500000 26110000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 484686000 484686000
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 3004366000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations -0.04 0.1
Diluted earnings (loss) per share from continuing operations -0.04 0.1
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -0.04 0.1
Diluted earnings (loss) per share from continuing and discontinued operations -0.04 0.1
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results
Textual Information(1) 1. The above standalone audited financial results of the Company have been prepared in accordance with the Indian Accounting Standards IND AS prescribed under section 133 of the Companies Act 2013 the Act read with relevant rules issued thereunder other accounting principles generally accepted in India and guidelines issued by the Securities and Exchange Board of India. n2. The Company owns 49 perecent Equity in Ms. Flow Tech Chemicals P Limited as on 31st March 2025 and is being given treatment of Associate Concern as per applicable IND AS. Accordingly the audited Financial Results for the Quarter and Year ended 31st March, 2025 are prepared on Consolidated and Standalone basis.t n3. The figures for the last quarter are the balancing figures between the audited figures in respect of the full financial year ended 31st March, 2025 and the unaudited published year to date figures upto the third quarter ended 31st December 2024 which were subject to limited review.ttttt n4. The Company operates in a single business segment viz. Chemicals. n5. The company had made investments of Rs.5299.81 Lakhs in equity shares of Flow Tech Chemicals Pvt. Ltd. The valuation of investment as on 31.03.2025 was done by registered valuer based on expected profits following the assumption consistently for the next five years in the financial year. As per the valuation the valuation on investment as on 31.03.2025 is on the higher side resulting in no impairment provision being provided as on 31.03.2025.ttttt n6. The figures of the previous period have been regrouped or reclassified wherever necessary. n7. The above results have been reviewed by the Audit Committee and thereafter approved by the Board in its meeting held on 30th May 2025.ttttt n



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 4969144000
Capital work-in-progress 102605000
Investment property 0
Goodwill 0
Other intangible assets 530000
Intangible assets under development 0
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 529981000
Trade receivables, non-current 0
Loans, non-current 0
Other non-current financial assets 218949000
Total non-current financial assets 748930000
Deferred tax assets (net) 0
Other non-current assets 60165000
Total non-current assets 5881374000
2 Current assets
Inventories 338993000
Current financial asset
Current investments 0
Trade receivables, current 427710000
Cash and cash equivalents 1676000
Bank balance other than cash and cash equivalents 80787000
Loans, current 0
Other current financial assets 64217000
Total current financial assets 574390000
Current tax assets (net) 0
Other current assets 534248000
Total current assets 1447631000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 7329005000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 484686000
Other equity 3346016000
Total equity attributable to owners of parent 3830702000
Non controlling interest
Total equity 3830702000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 804724000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 0
Total non-current financial liabilities 804724000
Provisions, non-current 52218000
Deferred tax liabilities (net) 262364000
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities 1119306000
Current liabilities
Current financial liabilities
Borrowings, current 884361000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 117305000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 520203000
Total Trade payable 637508000
Other current financial liabilities 67584000
Total current financial liabilities 1589453000
Other current liabilities 777764000
Provisions, current 5689000
Current tax liabilities (Net) 6091000
Deferred government grants, Current 0
Total current liabilities 2378997000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 3498303000
Total equity and liabilites 7329005000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Other comprehensive income 1068000 3980000
Total Amount of items that will not be reclassified to profit and loss 1068000 3980000
2 Income tax relating to items that will not be reclassified to profit or loss 373000 1391000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income 695000 2589000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 151153000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 118034000
Adjustments for decrease (increase) in inventories -116334000
Adjustments for decrease (increase) in trade receivables, current -77747000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -119881000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current -26279000
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 208017000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 10507000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 511057000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current -1991000
Adjustments for provisions, non-current 3980000
Adjustments for other financial liabilities, current 6268000
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 1216000
Adjustments for dividend income 0
Adjustments for interest income 16765000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow -6900000
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) 493182000
Net cash flows from (used in) operations 644335000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 644335000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 19849000
Purchase of property, plant and equipment 401519000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 16765000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -64884000
Net cash flows from (used in) investing activities -429789000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 181576000
Repayments of borrowings 272013000
Payments of lease liabilities 6122000
Dividends paid 0
Interest paid 121024000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -217583000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -3037000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -3037000
Cash and cash equivalents cash flow statement at beginning of period 4713000
Cash and cash equivalents cash flow statement at end of period 1676000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 S. Tandon and Associates LLP Yes 30-Jun-2025


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Primo Chemicals Limited Flow Tech Chemicals Private Limited Associate Sale of goods or services Approved and Quarterly reviewed by Audit Committee 114398000 5362000 0
2 Primo Chemicals Limited Flow Tech Chemicals Private Limited Associate Any other transaction Neutralization Charges Approved and Quarterly reviewed by Audit Committee 972000 0 0
3 Primo Chemicals Limited Flow Tech Chemicals Private Limited Associate Any other transaction Chlorine Disposal or Handling Charges Approved and Quarterly reviewed by Audit Committee 133813000 0 -13821000
4 Primo Chemicals Limited Prayag Chemicals Private Limited Common Directors Sale of goods or services Approved and Quarterly reviewed by Audit Committee 5773000 6231000 0
5 Primo Chemicals Limited Prayag Chemicals Private Limited Common Directors Any other transaction Tonner Rent Chlorine Disposal and Handling Charges Approved and Quarterly reviewed by Audit Committee 13698000 0 -7850000
6 Primo Chemicals Limited Prayag Chemicals Private Limited Common Directors Any other transaction Lease Rent Approved and Quarterly reviewed by Audit Committee 180000 -227000 0
7 Primo Chemicals Limited V.S. Polymers Private Limited Common Directors Sale of goods or services Approved and Quarterly reviewed by Audit Committee 579000 140000 0
8 Primo Chemicals Limited V.S. Polymers Private Limited Common Directors Any other transaction Chlorine Disposal or Handling Charges Approved and Quarterly reviewed by Audit Committee 25611000 0 -17886000
9 Primo Chemicals Limited Durva Infratech LLP Share Holding More Than 10 percent Any other transaction Material or Equipment or Modification and commissioning of Power Plant Approved and Quarterly reviewed by Audit Committee 7500000 -216112000 -8700000 Textual Information(1)
10 Primo Chemicals Limited Shanhenshah Chemicals Common Directors or Partners Sale of goods or services Approved and Quarterly reviewed by Audit Committee 5686000 22000 280000
11 Primo Chemicals Limited Shri Jatin Dahiya Whole Time Director Remuneration Quarterly reviewed by Audit Committee 33006000 0 0
Total value of transaction during the reporting period 341216000



Text Block
Textual Information(1) Includes approved transaction of Rs.400 Lakhs excluding GST incurred during the FY 2024 25 towards balance amount of Purchase of Power Plant.